Urinary prostaglandin metabolites evaluation for activity monitoring in inflammatory bowel disease
Abstract Inflammatory bowel diseases cause chronic intestinal inflammation, including Crohn’s disease (CD) and ulcerative colitis (UC). Prostaglandin E-major urinary metabolite (PGE-MUM) is a urine biomarker for disease activity in IBD. This study evaluated PGE-MUM performance for predicting an acti...
Saved in:
Main Authors: | Renata d’Inca, Hana Manceau, Lucia Zanni, Laura Vernoux, Xavier Treton, Katell Peoc’h |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-78154-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammatory Bowel Diseases in Children: Modern Achievements in Diagnostics and Therapy
by: A. I. Khavkin, et al.
Published: (2024-01-01) -
Does faecal calprotectin differentiate between inflammatory bowel disease colitis and non-inflammatory bowel disease colitides?
by: Ahmed F. Khalil, et al.
Published: (2020-11-01) -
Release of prostaglandin D2 by murine mast cells: importance of metabolite formation for antiproliferative activity
by: C. Haberl, et al.
Published: (1998-01-01) -
The prevalence, characteristics, and determinants of anaemia in newly diagnosed patients with inflammatory bowel disease
by: Małgorzata Woźniak, et al.
Published: (2019-03-01) -
Leukocytapheresis in patients with inflammatory bowel diseases
by: Małgorzata Woźniak, et al.
Published: (2021-06-01)